Disparities and Therapeutic Advances in Cystic Fibrosis

Abstract excerpt

Cystic fibrosis has seen a multitude of therapeutic advances targeting its downstream effects. This has led to a steady increase in survival over the past few decades. The recent development of disease-modifying drugs targeting the underlying CFTR mutation has revolutionized treatment for CF. Despite these advances, individuals with CF who are racial and ethnic minorities, from low socioeconomic status, or female...

Topics

Open a Topic to create a Post that cites this publication.

• Cystic Fibrosis
• Cystic Fibrosis Transmembrane Conductance Regulator
• Disease Management
• Ethnicity
• Health Services Accessibility
• Healthcare Disparities
• Minority Groups
• Mutation

Identifiers and source

Literature Corpus work

d61fe4ca-c983-53aa-bdc7-b48e902ed60b

DOI

10.22541/au.167566153.31386136/v1